ISRCTN85255912已完成未知
Treatment of high risk testicular tumour with high dose chemotherapy with peripheral blood stem cells
Department of Health (UK)0 个研究点目标入组 6 人开始时间: 2003年9月12日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 6
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- Male
入选标准
- •1. Patients with histological proven non-seminomatous germ cell tumours
- •2. High risk factors as defined by MRC prognostic group
排除标准
- •Not provided at time of registration
研究者
相似试验
招募中
1 期
Treatment of High-Risk Prostate Cancer Guided by Novel Diagnostic Radio- and Molecular Tracers (THUNDER): A Two-part Phase 2/3 TrialProstate cancerCTIS2022-501551-90-00Gasthuiszusters Antwerpen493
撤回
不适用
Towards optimal treatment for high risk prostate cancer; stereotactic pelvic radiotherapy with focal boost to the primary tumorprostate cancerNL-OMON56376Haaglanden Medisch Centrum228
进行中（未招募）
不适用
TREATMENT OF NON-INVASIVE BLADDER CANCER WITH HIGH RISK OF RECURRENCE – BLUE LIGHT CYSTOSCOPY WITH CHEMOTHERAPYbladder cancer (non-invasive Ta urothelial bladder cancer)EUCTR2012-000559-15-FIFinnBladder
已完成
不适用
Optimized Treatment Strategy for HighGrade1 (HGT1) Bladder Cancer Based on Substaging: a Prospective Observational Cohort StudyBladder CancerNCT02113501Hospital Universitari Vall d'Hebron Research Institute200
进行中（未招募）
Unknown
THERApy de-escalation for TESTicular cancerCancerISRCTN61007118Queen Mary University of London30